Group 1: Market Overview - On July 31, the Hong Kong stock market saw a net inflow of 13.126 billion HKD from northbound trading, with 7.604 billion HKD from Shanghai and 5.522 billion HKD from Shenzhen [2] - The most bought stocks included Yingfu Fund (02800), Hang Seng China Enterprises (02828), and Meituan-W (03690), while the most sold stocks were Laopu Gold (06181), CSPC Pharmaceutical Group (01093), and Shandong Molong (00568) [2][6] Group 2: Stock Performance - Meituan-W (03690) had a net buy amount of 2.622 billion HKD, while Laopu Gold (06181) faced a net sell of 2.78 billion HKD [3][7] - CSPC Pharmaceutical Group (01093) had a net sell of 891.29 million HKD, indicating a significant outflow [4][7] Group 3: Company Insights - Laopu Gold (06181) is expected to see a 26% year-on-year revenue growth next year, with adjusted net profit projected to rise by 30% [7] - The company plans to open six new boutique stores, with a projected 6% year-on-year increase in sales per store [7] - The target price for Laopu Gold has been adjusted down by 4% to 958 HKD, maintaining a "buy" rating despite concerns over sustainable profit growth [7] Group 4: Sector Analysis - The Hong Kong market is experiencing a robust inflow of funds, with a focus on technology and new consumption sectors, which are considered relatively scarce assets [5] - The technology sector is highlighted as a significant part of the Hong Kong market, accounting for nearly one-third, with ongoing revaluation expected [6]
北水成交净买入131.26亿 北水抢筹港股ETF及科网股 买入盈富基金超24亿港元
Zhi Tong Cai Jing·2025-07-31 19:08